How to Find Fertility Clinic Leads

Fertility care has consolidated faster than almost any other outpatient specialty over the past decade, and the CDC's own IVF-cycle reporting data shows it plainly: 17 of 464 reporting clinics (3.7%) were private-equity affiliated in 2013, performing 13.3% of IVF cycles that year; by the end of 2023, 163 of 507 reporting clinics (32.1%) were PE-affiliated, performing 54.0% of all US IVF cycles, a clear majority. In 13 states and Washington, DC, PE- or VC-affiliated clinics now perform between 63% and 100% of all IVF cycles in that state or region. A purchased clinic directory built from licensing boards or scraped websites reflects a clinic's name, address, and specialty; it has no field for which platform now owns it, and ownership is exactly what determines whether a vendor pitch goes to a physician-owner with full purchasing authority or gets redirected to a platform's central operations team that already has a preferred-vendor list.

A handful of specific, publicly findable events predict whether a fertility clinic is actually worth calling right now. The clearest is a new platform acquisition or affiliation announcement: when a clinic joins US Fertility (which grew to 120 clinics nationwide after acquiring Piedmont Reproductive Endocrinology Group in January 2026), Inception Fertility, Pinnacle Fertility, IVI-RMA's Eugin Group, Kindbody, or Boston IVF, the acquiring platform typically runs a vendor and tech-stack consolidation review across the newly added clinic within its first months on the platform, which means the sales conversation moves from the local clinic to the platform's corporate procurement team almost overnight. A second signal is a job posting or site reference naming a specific EMR or practice-management system, established players include Meditab's fertility EHR, Fertility Pro, Mellowood Medical, and DocEngage, since a posting naming one of these signals either active onboarding or an evaluation already underway. A third is a new reproductive endocrinologist or embryology lab director hire, which typically precedes either a brand-new clinic opening or a major capacity expansion at an existing one, both of which mean a from-scratch or expanded lab-systems and financing buildout. None of this shows up in a licensing roster; all of it shows up in M&A trade press, job postings, and clinic site updates an AI agent can monitor continuously.

Instead of buying a list of every fertility clinic in a territory and pitching a PE-platform-owned clinic the same way as a still-independent, physician-owned practice, describe the buying behavior that actually matters to your product in plain language and let an AI signals agent search the open web for matches. For an EMR or practice-management vendor, that might mean scanning for clinics whose job postings reference a competing system by name, or newly affiliated clinics about to go through their new platform's first-year tech-stack review. For a patient-financing or lab-systems vendor, it might mean tracking clinics that just announced a new location or a new REI hire, since either one means a from-scratch buildout with no incumbent vendor relationship yet. Avina's Custom AI Signals let you write that targeting criteria as a plain-language description; the AI Signals Agent then scans M&A trade press, job postings, and clinic site updates continuously and surfaces matching fertility clinics as they appear, instead of handing you a static roster with no way to tell a newly consolidated clinic from one that's operated unchanged for a decade.